New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
07:56 EDTPBHWorst is behind Prestige Brands, says Oppenheimer
After Prestige Brands reported Q3 results that Oppenheimer views as disappointing, the firm thinks the company is still poised to create value over the long-term. It keeps an Outperform rating on the stock.
News For PBH From The Last 14 Days
Check below for free stories on PBH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
12:58 EDTPBHOn The Fly: Midday Wrap
Subscribe for More Information
12:00 EDTPBHPrestige Brands rises 5.3%
Subscribe for More Information
10:00 EDTPBHPrestige Brands rises 7.8%
Prestige Brands is up 7.8%, or $2.07, to $28.69
09:34 EDTPBHPrestige Brands upgraded to Buy from Neutral at Sidoti
07:01 EDTPBHPrestige Brands to acquire Hydralyte from The Hydration Pharmaceuticals Trust
Prestige Brands announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia. The acquisition is expected to close, subject to customary closing conditions, during 1Q115, which began on April 1. The acquisition is projected to double the annual revenues of Care Pharmaceuticals, Prestige’s subsidiary in Australia, to approximately A$50M for FY15, and is expected to be accretive to Prestige’s EPS for FY15, exclusive of transaction, integration and purchase accounting items. Prestige acquired Care Pharmaceuticals in July 2013. Financial terms of the acquisition have not been disclosed. Prestige funded this acquisition, its fifth in the past five years, with a combination of cash on the balance sheet and its existing credit facility with very minimal impact on the company’s leverage ratio or M&A capacity.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use